J. Cunanan

发表

Upregulation of Surrogate Markers of Inflammation and Thrombogenesis in Patients With ESRD: Pathophysiologic and Therapeutic Implications

K. Nelson, I. Thethi, J. Cunanan, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inflammatory and Procoagulant Cytokine Levels During Pregnancy as Predictors of Adverse Obstetrical Complications

J. Cunanan, D. Hoppensteadt, J. Fareed, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Comparative Studies on Branded Enoxaparin and a US Generic Version of Enoxaparin

J. Cunanan, D. Hoppensteadt, J. Fareed, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Thrombin Generation Mediators and Markers in Sepsis-Associated Coagulopathy and Their Modulation by Recombinant Thrombomodulin

J. Cunanan, D. Hoppensteadt, J. Fareed, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Comparative Anticoagulant and Platelet Modulatory Effects of Enoxaparin and Sulodexide

J. Cunanan, D. Hoppensteadt, J. Fareed, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cross-Reactivity of Various Thrombin Products With Anti-Rabbit Antibodies to Bovine, Human, and Recombinant Thrombin

J. Cunanan, D. Hoppensteadt, J. Fareed, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cross-Reactivity of Rabbit Anti-Bovine Thrombin IgGs With Human α-Thrombin and a Recombinant Version of Human Thrombin (Recothrom)

J. Cunanan, D. Hoppensteadt, J. Fareed, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Increased Prevalence of Antiheparin Platelet Factor 4 Antibodies in Patients May Be Due to Contaminated Heparin

K. Nelson, J. Cunanan, D. Hoppensteadt, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Biological Profile of the Hyper/Oversulfated Chondroitin Sulfate Contaminant Isolated from Recalled Heparin

R. Linhardt, J. Cunanan, D. Hoppensteadt, 2008 .

Upregulation of Microparticles in DIC and its Impact on Inflammatory Processes

I. Thethi, J. Cunanan, D. Hoppensteadt, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Differential thrombin generation inhibition by branded and generic low molecular weight heparins (LMWHs) as studied using a fluorescence substrate based kinetic method

J. Cunanan, D. Hoppensteadt, J. Fareed, 2009 .

Reduced Immunogenic Potential of Membrane Filtered Bovine Thrombin Preparations for Hemostatic Application

J. Cunanan, D. Hoppensteadt, J. Fareed, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prolonged Administration of Defibrotide Is Non-Immunogenic in Rats and Dogs.

M. Iacobelli, J. Cunanan, D. Hoppensteadt, 2009 .

Diff erences in pharmacokinetic behaviour of branded enoxaparin and a US generic version in a non-human primate model

Phd, J. Cunanan, D. Hoppensteadt, 2015 .

Gender-based differences in hemostatic responses.

J. Cunanan, D. Hoppensteadt, J. Fareed, 2012, Personalized medicine.

A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin.

A. Bayol, J. Cunanan, J. Fareed, 2011, Thrombosis research.

Variations in the Circulating Heparin Levels During Maintenance Hemodialysis in Patients With End-Stage Renal Disease

J. Cunanan, D. Hoppensteadt, J. Fareed, 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemodialysis Mediated Upregulation of Myeloperoxidase in End Stage Renal Disease: Pathophysiologic Implications

J. Cunanan, D. Hoppensteadt, J. Fareed, 2007 .

Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.

J. Cunanan, D. Hoppensteadt, J. Fareed, 2008, International Angiology.

Effect of Dabigatran and Rivaroxaban on thrombomodulin mediated activation of protein C and thrombin activated fibrinolysis inhibitor (TAFI)

J. Cunanan, D. Hoppensteadt, J. Fareed, 2012 .

Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?

J. Cunanan, J. Fareed, C. Adiguzel, 2008, International angiology : a journal of the International Union of Angiology.